Get started
Karyopharm Therapeutics Inc 6.0% 13-MAY-2029Karyopharm Therapeutics Inc 6.0% 13-MAY-2029Karyopharm Therapeutics Inc 6.0% 13-MAY-2029

Karyopharm Therapeutics Inc 6.0% 13-MAY-2029

No trades
See on Supercharts
Overview
Analysis

KPTI5813817 chart


Full chart

Key terms


Outstanding amount
—
Face value
1,000.00 USD
Minimum denomination
1,000.00 USD
Coupon
6.00% (Fixed)
Coupon frequency
Quarterly
Yield to maturity
15.52%
Maturity date
May 13, 2029
Term to maturity
3 years

About Karyopharm Therapeutics Inc 6.0% 13-MAY-2029


Issuer
Karyopharm Therapeutics, Inc.
Sector
Health Technology
Industry
Pharmaceuticals: Major
Home page
karyopharm.com
Issue date
May 16, 2024
FIGI
BBG01MS4J894
Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A. DePinho, Pamela A, Silver, Giulio Draetta, Michael G. Kauffman, and Sharon Shacham on December 22, 2008, and is headquartered in Newton, MA.

KPTI5813817 analysis


Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.

Dive into corporate with bonds that match in maturity and industry.